Market Overview

Perrigo Buys Remaining Stake in Cobrek Pharma for ~$45M

Share:
Related PRGO
Digesting Delivering Alpha 2017: The Top Picks You Need To Know
Benzinga's Top Upgrades, Downgrades For September 7, 2017

Perrigo Company (Nasdaq: PRGO) today announced that it has signed a definitive merger agreement and has completed the acquisition of Cobrek Pharmaceuticals, Inc. (Cobrek), a privately-held, Chicago, Illinois-based drug development company, for approximately $45 million on a cash free and debt free basis.

Posted-In: News M&A

 

Related Articles (PRGO)

View Comments and Join the Discussion!
Loading...
Loading...